Japan market access turns on local licensing, notifications, Japanese-language labeling, and classification between cosmetics and quasi-drugs before retailer listing.
Beauty brands preparing for Japanese retail channels such as @cosme Store, Loft, Plaza, Don Quijote, Matsumoto Kiyoshi, and related channels.
Use it before market-access planning, local responsible-party setup, product classification, label translation, testing, or retailer listing.
The market-access baseline, local labels, responsible-party evidence, and retailer listing packet should agree.
Translate the review into evidence a team can actually assemble: source files, structured fields, owners, reviewer decisions, and renewal dates.
classification analysis, importer license evidence, cosmetic notification, quasi-drug approval where relevant, GMP inspection evidence, formula, ingredient screen, Japanese labels, safety records, and claims support mAH or importer responsibility documentation
Shows whether the product can meet Japan PMD Act cosmetics and quasi-drugs expectations without a late reformulation.
Classification review, Ingredient conformity, GMP inspection where relevant, Label review, Safety evidence
Gives reviewers batch-level evidence instead of a generic quality claim.
Facility certification, supplier specs, source documents, change records, and renewal dates.
Keeps manufacturer evidence reusable without hiding retailer-specific gaps.
Claim library, certifications, labels, PDP copy, supplier attestations, and reviewer decisions.
Prevents unsupported claims from becoming retailer review or delisting risk.
Importer licensing, Notification, Quasi-drug approval, Japanese labels, Retailer listing
Catches the shipment and portal details that can block a launch after product approval.
Confirm the product, category, market, retailer program, and responsible internal owner.
Screen the formula, ingredients, supplier trade names, and claim language against the retailer overlay.
Collect supplier documents, facility certifications, SDS files, COAs, specifications, and attestations.
Validate testing coverage, lab accreditation, batch scope, freshness, and finished-product alignment.
Prepare claims substantiation and certification evidence before the buyer or portal review.
Map documents to the retailer submission packet, portal workflow, and renewal calendar.
Check logistics readiness: GS1, GTIN, carton labels, ASN, EDI, routing guide, and chargeback triggers.
Monitor formula, supplier, certification, label, and requirement changes after onboarding.
Market-access evidence can be mistaken for a retailer formality even though the local responsible party, classification, filing, or listing controls whether the product can be sold.
Resolve classification, responsible-party records, filings, labels, and test evidence before retailer listing work begins.
Entering retail without the correct local license path. becomes a launch blocker when the team cannot show the exact evidence behind that statement.
Assign this check to a packet owner, attach the source file or data field that proves it, and record the reviewer decision before submission.
A COA that is generic, stale, or tied to the wrong batch leaves the reviewer without product-specific evidence.
Match each COA to the finished product, lot or batch, lab, method, test date, and freshness window required for the review.
Claims can drift between labels, PDPs, sell sheets, and buyer decks after the evidence packet is assembled.
Review every claim against source evidence, certification scope, formula data, and the live label or PDP before submission.
Leave your details and we will help you turn this guide into a practical checklist for your retailer submission, renewal, or manufacturer document request.
Valent helps brands and manufacturers map documents, tests, certifications, formulas, claims, and operational fields to retailer-specific requirements so teams can fix gaps before reviews, renewals, or shipments are at risk.
Talk with ValentStart with the Japan PMD Act cosmetics and quasi-drugs review path, then build the packet around the evidence a reviewer will actually ask for: product data, supplier documents, current certifications, SDS where relevant, COAs or testing evidence, claim support, labels, insurance, and operational setup records.
It depends on the product category and review path. Check whether the retailer expects a facility certificate, product certification, audit report, or accepted third-party framework, then confirm the scope, issuing body, and expiration date.
COAs and lab tests are commonly relevant for supplements, food, cosmetics, and products with safety, purity, contaminant, or claim risks. Retailer-ready COAs should match the finished product or batch and should identify the lab, method, date, and tested attributes.
The slowdowns are usually evidence mismatches: stale certificates, incomplete supplier data, missing fragrance or allergen support, COAs tied to the wrong product or batch, unsupported claims, portal-field mismatches, insurance language issues, and EDI or carton-label errors.
Yes. Contract manufacturers can standardize formula, specification, COA, SDS, allergen, facility, batch, and supplier packets, then keep retailer-specific overlays separate so brand customers receive evidence that maps to the program they are pursuing.
Usually not. Use public Japan PMD Act cosmetics and quasi-drugs information for preparation, then confirm the current submission packet in the retailer portal, supplier manual, screening platform, or compliance-team channel.